Generic substitution for cyclosporine: what should we be looking for in new formulations?
Johnston
A
A
Department of Clinical Pharmacology, St Bartholomew's Hospital, London, United Kingdom.
Holt
D W
DW
D016572:Cyclosporine / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D004304:Dosage Forms; D016568:Drugs, Generic; D006084:Graft Rejection / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D012307:Risk Factors
D004304:Dosage Forms; D016568:Drugs, Generic; D007166:Immunosuppressive Agents; D016572:Cyclosporine